Development and Preclinical Evaluation of a Copper-64-Labeled Antibody Targeting Glycine-Alanine Dipeptides for PET Imaging of C9orf72‑Associated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
Article in ACS Pharmacology & Translational Science (April 2024)